APULI MARICEL (Chief Accounting Officer) reported 1 transaction at BRIDGEBIO PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/19/2026ACC: 0001470831-26-000471
Officer· Chief Accounting Officer
Since Feb 2026
-4.71K
Net shares
Net seller
$311.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.71K
Price / share
$66.13
Trade value
$311.74K
% of position
3.5%
5/16/2026
134.12K→129.40K
Total
Net shares
−4.71K
Net value
-$311.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2026 | F · Tax Withholding | −4.71K | $66.13 | $311.74K | 3.5% | 134.12K | 129.40K |
| Total | −4.71K | -$311.74K | ||||||
Derivative Transactions0
No derivative transactions reported